117 related articles for article (PubMed ID: 37540156)
1. Association between clinical features and course of systemic sclerosis and serum interleukin-8, vascular endothelial growth factor, basic fibroblast growth factor, and interferon alpha.
Kosałka-Węgiel J; Lichołai S; Dziedzina S; Milewski M; Kuszmiersz P; Korona A; Korkosz M; Gąsior J; Matyja-Bednarczyk A; Kwiatkowska H; Siwiec-Koźlik A; Sydor W; Wilańska J; Zaręba L; Pociej-Marciak W; Dropiński J; Sanak M; Musiał J; Bazan-Socha S
Adv Clin Exp Med; 2024 Apr; 33(4):369-377. PubMed ID: 37540156
[TBL] [Abstract][Full Text] [Related]
2. Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers.
Distler O; Del Rosso A; Giacomelli R; Cipriani P; Conforti ML; Guiducci S; Gay RE; Michel BA; Brühlmann P; Müller-Ladner U; Gay S; Matucci-Cerinic M
Arthritis Res; 2002; 4(6):R11. PubMed ID: 12453314
[TBL] [Abstract][Full Text] [Related]
3. Serum IL-17 and TNFα as prognostic biomarkers in systemic sclerosis patients: a prospective study.
Kosałka-Węgiel J; Lichołai S; Pacholczak-Madej R; Dziedzina S; Milewski M; Kuszmiersz P; Korona A; Gąsior J; Matyja-Bednarczyk A; Kwiatkowska H; Zaręba L; Siwiec-Koźlik A; Koźlik-Siwiec P; Wach A; Pociej-Marciak W; Sanak M; Musiał J; Bazan-Socha S; Korkosz M
Rheumatol Int; 2024 Jan; 44(1):119-128. PubMed ID: 38051374
[TBL] [Abstract][Full Text] [Related]
4. Circulating angiogenesis inhibitor endostatin and positive endothelial growth regulators in patients with systemic lupus erythematosus.
Robak E; Woźniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
Lupus; 2002; 11(6):348-55. PubMed ID: 12139372
[TBL] [Abstract][Full Text] [Related]
5. Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival.
Ugurel S; Rappl G; Tilgen W; Reinhold U
J Clin Oncol; 2001 Jan; 19(2):577-83. PubMed ID: 11208853
[TBL] [Abstract][Full Text] [Related]
6. [Altered serum cytokine expression profile in systemic sclerosis and its regulatory mechanisms].
Zhu HL; DU Q; Chen WL; Zuo XX; Li QZ; Liu SJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Aug; 51(4):716-722. PubMed ID: 31420628
[TBL] [Abstract][Full Text] [Related]
7. Effect of interferon alpha and ribavirin treatment on serum levels of transforming growth factor-beta1, vascular endothelial growth factor, and basic fibroblast growth factor in patients with chronic hepatitis C.
Janczewska-Kazek E; Marek B; Kajdaniuk D; Borgiel-Marek H
World J Gastroenterol; 2006 Feb; 12(6):961-5. PubMed ID: 16521228
[TBL] [Abstract][Full Text] [Related]
8. Associations between circulating endostatin levels and vascular organ damage in systemic sclerosis and mixed connective tissue disease: an observational study.
Reiseter S; Molberg Ø; Gunnarsson R; Lund MB; Aalokken TM; Aukrust P; Ueland T; Garen T; Brunborg C; Michelsen A; Abraityte A; Hoffmann-Vold AM
Arthritis Res Ther; 2015 Aug; 17(1):231. PubMed ID: 26315510
[TBL] [Abstract][Full Text] [Related]
9. Nifedipine decreases sVCAM-1 concentrations and oxidative stress in systemic sclerosis but does not affect the concentrations of vascular endothelial growth factor or its soluble receptor 1.
Allanore Y; Borderie D; Lemaréchal H; Ekindjian OG; Kahan A
Arthritis Res Ther; 2004; 6(4):R309-14. PubMed ID: 15225366
[TBL] [Abstract][Full Text] [Related]
10. Angiogenic and immune parameters during recombinant interferon-alpha2b adjuvant treatment in patients with melanoma.
Dréau D; Foster M; Hogg M; Swiggett J; Holder WD; White RL
Oncol Res; 2000; 12(5):241-51. PubMed ID: 11417749
[TBL] [Abstract][Full Text] [Related]
11. Early systemic sclerosis: serum profiling of factors involved in endothelial, T-cell, and fibroblast interplay is marked by elevated interleukin-33 levels.
Vettori S; Cuomo G; Iudici M; D'Abrosca V; Giacco V; Barra G; De Palma R; Valentini G
J Clin Immunol; 2014 Aug; 34(6):663-8. PubMed ID: 24760110
[TBL] [Abstract][Full Text] [Related]
12. Imbalanced serum levels of Ang1, Ang2 and VEGF in systemic sclerosis: Integrated effects on microvascular reactivity.
Michalska-Jakubus M; Cutolo M; Smith V; Krasowska D
Microvasc Res; 2019 Sep; 125():103881. PubMed ID: 31075243
[TBL] [Abstract][Full Text] [Related]
13. Circulating angiogenic cytokines in multiple myeloma and related disorders.
Urba ska-Rys H; Wierzbowska A; Robak T
Eur Cytokine Netw; 2003; 14(1):40-51. PubMed ID: 12799213
[TBL] [Abstract][Full Text] [Related]
14. Decreased ratio of circulatory vascular endothelial growth factor to endostatin in patients with systemic sclerosis--association with pulmonary involvement.
Dziankowska-Bartkowiak B; Waszczykowska E; Dziankowska-Zaboroszczyk E; de Graft-Johnson JE; Zalewska A; Łuczyńska M; Nowak D
Clin Exp Rheumatol; 2006; 24(5):508-13. PubMed ID: 17181918
[TBL] [Abstract][Full Text] [Related]
15. Selected growth factors in peritoneal dialysis: their relationship to markers of inflammation, dialysis adequacy, residual renal function, and peritoneal membrane transport.
Stompór T; Zdzienicka A; Motyka M; Dembińska-Kieć A; Davies SJ; Sulowicz W
Perit Dial Int; 2002; 22(6):670-6. PubMed ID: 12556068
[TBL] [Abstract][Full Text] [Related]
16. Angiogenic and inflammatory biomarkers for screening and follow-up in patients with pulmonary arterial hypertension.
Kylhammar D; Hesselstrand R; Nielsen S; Scheele C; Rådegran G
Scand J Rheumatol; 2018 Jul; 47(4):319-324. PubMed ID: 29528272
[TBL] [Abstract][Full Text] [Related]
17. Association of elevated α-defensin levels with interstitial pneumonia in patients with systemic sclerosis.
Sakamoto N; Kakugawa T; Hara A; Nakashima S; Yura H; Harada T; Ishimoto H; Yatera K; Kuwatsuka Y; Hara T; Ichinose K; Obase Y; Ishimatsu Y; Kohno S; Mukae H
Respir Res; 2015 Dec; 16():148. PubMed ID: 26654954
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of the angiogenic cytokines basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in multiple myeloma.
Sezer O; Jakob C; Eucker J; Niemöller K; Gatz F; Wernecke K; Possinger K
Eur J Haematol; 2001 Feb; 66(2):83-8. PubMed ID: 11168514
[TBL] [Abstract][Full Text] [Related]
19. [Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) are elevated in peripheral blood plasma of patients with chronic lymphocytic leukemia and decrease after intensive fludarabine-based treatment].
Smolej L; Andrýs C; Krejsek J; Belada DZ; Zák P; Siroký O; Malý J
Vnitr Lek; 2007 Nov; 53(11):1171-6. PubMed ID: 18277626
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of subclinical atherosclerosis is increased in systemic sclerosis and is associated with serum proteins: a cross-sectional, controlled study of carotid ultrasound.
Schiopu E; Au KM; McMahon MA; Kaplan MJ; Divekar A; Singh RR; Furst DE; Clements PJ; Ragvendra N; Zhao W; Maranian P; Khanna D
Rheumatology (Oxford); 2014 Apr; 53(4):704-13. PubMed ID: 24357811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
